Regulatory requirements on shareholders’ reduction in the working letter on micro chip biological income supervision

According to the short form equity change report released by microchip on the evening of October 13, Pingxiang Yongzhi Yinghua Yuanfeng investment partnership (limited partnership) (hereinafter referred to as “Pingxiang Yongzhi”) sold 1.9221 million shares of microchip bio shares held by Pingxiang Yongzhi through block trading on October 12, 2020, accounting for 0.4688% of the total equity, and the price range of reduction was 48.91 to 50.31 yuan / share. Before the equity change, Pingxiang Yongzhi held 22.422 million shares of micro core bio, accounting for 5.47% of the total equity of microchip biology, and was a shareholder of more than 5% of the total equity of microchip biology. < / P > < p > after the equity change, as of the signing date of the report, Pingxiang Yongzhi held 20.4999 million shares of microchip biology, which were non tradable shares, accounting for 4.99998% of the total equity of microchip. < / P > < p > in addition to this equity change, Pingxiang Yongzhi reduced 5.9 million shares of microchip biology through block trading from August 31 to September 23, with the reduction ratio of 1.4390%, and the price range of reduction was 48.91-50.31 yuan / share. According to the report, < / P > < p > on August 14, 2020, microchip disclosed the reduction plan of Pingxiang Yongzhi. Pingxiang Yongzhi plans to reduce the total holding of no more than 28.322 million shares by means of centralized bidding, block trading and agreement transfer, that is, no more than 100% of the company’s shares and no more than 6.91% of the total share capital of the company. Pingxiang Yongzhi was registered by China Securities Investment Fund Industry Association on May 14, 2018. On June 19, 2020, Pingxiang Yongzhi successfully applied for the reduction policy of venture capital fund shareholders, and the reduction is not subject to the proportion limit. < / P > < p > as of the disclosure date of the report, Pingxiang Yongzhi has completed the reduction of 7.8221 million shares through block trading, accounting for 1.9078% of the total share capital of the company. The above reduction plan has not yet been completed, and a total of 20.4999 million shares have not been completed through centralized bidding and block trading. It will continue to reduce its holdings according to the above plan. According to public data, as of June 30, 2020, the largest shareholder of microchip biology is Boao group, with 42.9196 million shares, accounting for 10.47%. Pingxiang Yongzhi holds 28.322 million shares, accounting for 6.91%, ranking the second largest shareholder. < / P > < p > Disclaimer: the purpose of this article reprinted by china.com finance and economics is to convey more information and does not represent the views and positions of the website. The content of this paper is for reference only and does not constitute investment advice. Investors operate accordingly and bear their own risks. < p > < p > Chinanet is a national key news website under the leadership of the Information Office of the State Council and managed by China foreign language publishing and Distribution Bureau. Through 11 versions in 10 languages, the website releases information 24 hours a day, which is an important window for China to carry out international communication and information exchange.